Skip to main content

Animations

MJFF Publications

8281 - 8290 of 9038 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2018
  • 2016
  • 2013
  • 2011
  • 2018
  • 2021
  • 2022
  • Summary Details
    OPEN
    Title: Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-191590
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11481-019-09835-4
    Citation Count: 111
  • Summary Details
    OPEN
    Title: The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27614
    Citation Count: 94
  • Summary Details
    OPEN
    Title: Early detection of Parkinson’s disease through patient questionnaire and predictive modelling
    Journal Name: International Journal of Medical Informatics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ijmedinf.2018.09.008
    Citation Count: 98
  • Summary Details
    OPEN
    Title: Perspective: Data sharing for discovery
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/538s4a
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Parkinson's Disease Biomarkers: Resources for Discovery and Validation
    Journal Name: Neuropsychopharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/npp.2013.246
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Panels, Mini-Panels and Study Groups
    Journal Name: Neuropsychopharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/npp.2011.290
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Abstracts from the 50th European Society of Human Genetics Conference: Posters
    Journal Name: European Journal of Human Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41431-018-0247-7
    Citation Count: 0
  • Dysregulated miRNAs mark Parkinson’s disease progression
    2021
    Summary Details
    RESTRICTED
    Title: Dysregulated miRNAs mark Parkinson’s disease progression
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00046-2
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Brain atrophy in prodromal synucleinopathy is shaped by structural connectivity and gene expression
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awac187
    Citation Count: 52
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.